Testosterone and dihydrotestosterone are significant drivers of male external genital development, and therefore teratogens that alter these hormone profiles have been hypothesized to cause aberrations in development. Here, we present the first case report of genitalia anomalies after prenatal exposure to spironolactone and dutasteride through 8-weeks of gestation. The patient was born with abnormal male external genitalia which was surgically managed. Long-term outcomes such as gender identity, sexual function, hormonal maturation through puberty, and fertility remain unknown. These numerous considerations necessitate multi-disciplinary management with close follow-up to address sexual, psychological, and anatomic concerns.
|State||Accepted/In press - 2023|
Bibliographical notePublisher Copyright:
© 2023 Elsevier Inc.
- 5-alpha reductase deficiency
- Ambiguous genitalia
- Differences in sexual development
ASJC Scopus subject areas